INTRODUCTION: The principles of radiosurgery were developed in 1951 by Leksell. Their technical realization led to the development of the gamma knife and stereotactically modified linear accelerator. METHODS: In addition to the gamma knife, we present the different principles of convergent beam irradiation (radiosurgery with linear accelerator), the further development to fractionated stereotactic conformal radiotherapy, and the necessary quality-assurance steps. RESULTS: The greatest uncertainties in the precision of radiosurgery result from medical imaging (CT 0.7 x 0.7 x 1 mm; DSA 1-5 mm; MR angiography < 2 mm). The focusing accuracy of the gamma knife (+/- 0.3 mm) can also be achieved today by linear accelerators using a stereotactic floorstand. For the same indication and the same dosage for the target volume, there are no clinical differences between the gamma knife and the linear accelerator (AVM: 80% complete obliteration; metastases: 85% local tumor control; AN: 90% tumor control). However, there are greater differences in costs. There is no constellation where the gamma knife is just as expensive or more cost-effective than the linear accelerator treatment. The most cost-effective solution is modification of an available linear accelerator, resulting in treatment costs per patient of 9,201.25 DM (50 patients/year). CONCLUSION: There seem to be no methodological, physical, clinical or cost reasons for using a gamma knife, especially because the trend is going towards fractionated conformation radiotherapy instead of the application of high single doses.
INTRODUCTION: The principles of radiosurgery were developed in 1951 by Leksell. Their technical realization led to the development of the gamma knife and stereotactically modified linear accelerator. METHODS: In addition to the gamma knife, we present the different principles of convergent beam irradiation (radiosurgery with linear accelerator), the further development to fractionated stereotactic conformal radiotherapy, and the necessary quality-assurance steps. RESULTS: The greatest uncertainties in the precision of radiosurgery result from medical imaging (CT 0.7 x 0.7 x 1 mm; DSA 1-5 mm; MR angiography < 2 mm). The focusing accuracy of the gamma knife (+/- 0.3 mm) can also be achieved today by linear accelerators using a stereotactic floorstand. For the same indication and the same dosage for the target volume, there are no clinical differences between the gamma knife and the linear accelerator (AVM: 80% complete obliteration; metastases: 85% local tumor control; AN: 90% tumor control). However, there are greater differences in costs. There is no constellation where the gamma knife is just as expensive or more cost-effective than the linear accelerator treatment. The most cost-effective solution is modification of an available linear accelerator, resulting in treatment costs per patient of 9,201.25 DM (50 patients/year). CONCLUSION: There seem to be no methodological, physical, clinical or cost reasons for using a gamma knife, especially because the trend is going towards fractionated conformation radiotherapy instead of the application of high single doses.
Authors: Tushar Kumar; Joseph Rakowski; Bo Zhao; Mazin Alkhafaji; Jacob Burmeister; Tammy Austin; Maria Vlachaki Journal: J Appl Clin Med Phys Date: 2010-07-02 Impact factor: 2.102